Financially established women in their late 30s to mid-40s who are proactively researching IVF, egg freezing, donor eggs, and surrogacy as a planned life decision. Birth rates among U.S. women aged 40–44 rose 127% since 1990 and now outpace teen birth rates for the first time in history. These women want honest, expert information to compare expensive options — and they have the money to act.
Birth rates for U.S. women aged 40–44 rose 2% again from 2023 to 2024 (CDC, July 2025), and births to women 40+ now make up 4.3% of all U.S. births as of 2025 — up from 1.2% in 1990 — creating a larger and still-growing pool of intended parents actively researching assisted reproduction.
The donor egg IVF market grew from $2.74B in 2025 to $3.01B in 2026 at a 10.31% CAGR (Research and Markets, 2026), meaning clinic and agency revenue is compounding fast and the advertising auction for this audience is intensifying — early-mover distribution advantage matters now.
On May 10, 2026, the federal government proposed new 'Limited Excepted Benefits for Fertility and Reproductive Health Care' rules that would let employers offer standalone IVF coverage more easily — 65% of workers say they would change jobs for fertility benefits (Carrot Fertility via Rescripted, Feb 2026), so employer benefit budgets are becoming a new, large acquisition channel for clinics and agencies.
The exact words they type into Google.
Create a free account to unlock the full breakdown — all 3 ideas and every community map on the site.
Free forever. No credit card. Takes 20 seconds.
Also in Health. Sorted by how fast they are growing.
Med spa owner-operators — NPs, PAs, and physicians running revenue-generating aesthetic practices — are facing a wave of new state laws, active enforcement sweeps, and license revocation risk. With 2026 marking the first year of direct legislative regulation in multiple states, owners need operational compliance infrastructure now: the right agreements, SOPs, and physician oversight structures to protect their license and revenue stream.
Affluent adults aged 35–60 who already biohack their health are self-administering injectable peptides to lose fat, recover faster, slow aging, and boost performance. They pay $200–$1,000 per month out of pocket with no insurance coverage, yet have almost no trusted tools to verify product purity, guide protocol decisions, or track results.
People with health insurance who just got a denial letter and want to fight it but feel buried in paperwork and jargon. AI tools now generate the full appeal letter in under 60 seconds, removing the only real barrier that stopped most people from winning money that was already owed to them.
College-educated women ages 25–55 who spent years getting dismissed by conventional doctors are now self-directing their own SIBO and gut recovery protocols through stacked supplements, at-home breath tests, and functional medicine telehealth. Their core goal is getting their daily life back after years of debilitating bloating, pain, and misdiagnosis — not wellness optimization.